University College London begins preclinical studies to develop a

First company in the world to offer preclinical drug tests for children with cancer - Hopp-Kindertumorzentrum Heidelberg - KiTZ

The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studies - eBioMedicine

NovalGen receives CTA approval to start a Phase 1/2 first in human study to evaluate the safety, pharmacokinetics and efficacy of NVG-111 in Chronic Lymphocytic Leukemia & Mantle Cell Lymphoma - 07 - 04 - 2021 - UCLB

Stimulating Research, ASGCT - American Society of Gene & Cell Therapy

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial - The Lancet

University College London begins preclinical studies to develop a treatment for Niemann Pick C disease with support from the Columbus Foundation – Columbus Children's Foundation

Overview of current base editing clinical trials. Left: a simplified

A stroke recovery trial development framework: Consensus-based core recommendations from the Second Stroke Recovery and Rehabilitation Roundtable - Julie Bernhardt, Kathryn S Hayward, Numa Dancause, Natasha A Lannin, Nick S Ward, Randolph

Best Practices In Preclinical Development Of Cell Therapy Products

An equitable, community-engaged translational framework for science in human lactation and infant feeding—a report from “Breastmilk Ecology: Genesis of Infant Nutrition (BEGIN)” Working Group 5 - The American Journal of Clinical Nutrition

Benefits and obstacles to cell therapy in neonates: The INCuBAToR (Innovative Neonatal Cellular Therapy for Bronchopulmonary Dysplasia: Accelerating Translation of Research) - Thébaud - 2021 - STEM CELLS Translational Medicine - Wiley Online Library